Optiscan Imaging Management

Management criteria checks 2/4

Optiscan Imaging's CEO is Camile Farah, appointed in Dec 2021, has a tenure of 2.5 years. total yearly compensation is A$800.26K, comprised of 48.1% salary and 51.9% bonuses, including company stock and options. directly owns 0.78% of the company’s shares, worth A$1.17M. The average tenure of the management team and the board of directors is 2.5 years and 3.1 years respectively.

Key information

Camile Farah

Chief executive officer

AU$800.3k

Total compensation

CEO salary percentage	48.1%
CEO tenure	2.5yrs
CEO ownership	0.8%
Management average tenure	2.5yrs
Board average tenure	3.1yrs

Recent management updates

Recent updates

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Dec 02

CEO Compensation Analysis

How has Camile Farah's remuneration changed compared to Optiscan Imaging's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$5m
Jun 30 2023	AU$800k	AU$385k	-AU$4m
Mar 31 2023	n/a	n/a	-AU$5m
Dec 31 2022	n/a	n/a	-AU$5m
Sep 30 2022	n/a	n/a	-AU$4m
Jun 30 2022	AU$613k	AU$247k	-AU$4m
Mar 31 2022	n/a	n/a	-AU$4m
Dec 31 2021	n/a	n/a	-AU$3m
Sep 30 2021	n/a	n/a	-AU$3m
Jun 30 2021	AU$7k	n/a	-AU$2m

Compensation vs Market: Camile's total compensation ($USD531.21K) is above average for companies of similar size in the Australian market ($USD297.28K).

Compensation vs Earnings: Camile's compensation has increased whilst the company is unprofitable.

CEO

Camile Farah

2.5yrs

Tenure

AU$800,261

Compensation

Professor Camile Farah MBA, MAICD, PhD, FRACDS(OralMed), FAIM., serves as Chief Executive Officer and Executive Director of Optiscan Imaging Limited since December 13, 2021 and served as its Managing Direc...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Camile Farah	CEO & Executive Director	2.5yrs	AU$800.26k	0.78% A$ 1.2m
Brendan Fafiani	Chief Operating Officer	less than a year	no data	no data
Justin Mouchacca	Company Secretary	7.5yrs	AU$78.00k	no data

2.5yrs

Average Tenure

Experienced Management: OIL's management team is considered experienced (2.5 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Camile Farah	CEO & Executive Director	3.1yrs	AU$800.26k	0.78% A$ 1.2m
Robert Cooke	Non-Executive Chairman	3.2yrs	AU$100.45k	0.035% A$ 52.2k
Sean Gardiner	Non-Executive Director	2yrs	no data	no data
Ronnie Song	Non-Executive Director	3.3yrs	AU$55.25k	0.48% A$ 720.0k
Karen Borg	Independent Non-Executive Director	2.9yrs	AU$57.40k	0.012% A$ 18.0k

3.1yrs

Average Tenure

Experienced Board: OIL's board of directors are considered experienced (3.1 years average tenure).

Optiscan Imaging Management

Management criteria checks 2/4

Key information

Recent management updates

Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023

Optiscan Imaging Limited, Annual General Meeting, Nov 23, 2023

Less than half of directors are independent

Optiscan Imaging Limited, Annual General Meeting, Nov 24, 2022

Insider recently bought AU$1.9m worth of stock

Optiscan Imaging Limited Appointment of Sean Gardiner as Non-Executive Director

Recent updates

New minor risk - Share price stability

Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023

Full year 2023 earnings released: AU$0.007 loss per share (vs AU$0.007 loss in FY 2022)

Optiscan Imaging Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Financial data availability

New minor risk - Shareholder dilution

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.003 loss in 1H 2022)

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Full year 2022 earnings released: AU$0.007 loss per share (vs AU$0.004 loss in FY 2021)

Optiscan Imaging Limited, Annual General Meeting, Nov 24, 2022

Optiscan Submits FDA 510(k) Application for InVivage Device

Insider recently bought AU$1.9m worth of stock

Optiscan Imaging Limited Appointment of Sean Gardiner as Non-Executive Director

We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate

Less than half of directors are independent

Insider recently bought AU$1.2m worth of stock

Insider recently bought AU$1.4m worth of stock

Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business

Full year 2021 earnings released: AU$0.004 loss per share (vs AU$0.004 loss in FY 2020)

Non-Executive Director Graeme Mutton has left the company

We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn

Optiscan Imaging Limited Announces Update on seeking United States FDA approval & market entry

How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?

New 90-day high: AU$0.23

Optiscan Imaging Limited Announces Appointment of Ron Song as New Non-Executive Director

Optiscan Imaging Limited Announces Commencement of Stage Three of its Breast Cancer Study in Melbourne

OptiScan Imaging Limited Receives Orders from Carl Zeiss Meditec AG

Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?

Optiscan Imaging Limited Announces US FDA Regulatory Approval Update

Optiscan Imaging Limited announced that it expects to receive AUD 9.813499 million in funding from Orchid Fund Pte. Limited and other investors

Optiscan Imaging Limited Auditor Raises 'Going Concern' Doubt

Full year earnings released - AU$0.0037 loss per share

Optiscan Image Ltd Ordinary Shares to Be Deleted from Other OTC

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Board Members

Average Tenure